IMMUQUAD BIOSCIENCES
Immuquad Biosciences was founded by a research team from the University of Chicago in the United States. It is a national high-tech enterprise that focuses on changing the diagnosis and treatment of diseases by decoding the adaptive immune system, and is committed to promoting the development of immune-driven medicine . . Aimuan is at the forefront of adaptive immune system research. The self-developed immune medicine platform can reveal and translate the genetic code of the adaptive immune system and can be applied to immune-mediated diseases such as cancer, autoimmune diseases, and infectious diseases. in the diagnosis, monitoring, and treatment of sexually transmitted diseases.
IMMUQUAD BIOSCIENCES
Industry:
Biotechnology Health Care Life Science
Website Url:
http://www.immuquad.com
Status:
Active
Official Site Inspections
http://www.immuquad.com
- Host name: 121.40.253.228
- IP address: 121.40.253.228
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Immuquad Biosciences"
ImmuQuad Biotech - Crunchbase Company Profile
Organization. ImmuQuad Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
艾沐蒽® – 免疫驱动医学解决方案
数字化免疫力测评. Immun-Cheq ® | 免疫测评通过简单的采集血液样本，对受试者的免疫细胞受体基因进行二代测序和生物信息学临床分析后，获得的细胞免疫和体液免疫的多态性和克隆性， …See details»
关于我们 – 艾沐蒽® - immuquad.com
杭州艾沐蒽生物科技有限公司由美国芝加哥大学科研团队回国创办，是一家专注于通过解码适应性免疫系统来改变疾病的诊断和治疗，并致力于推进 免疫驱动医学 领域发展的 国家级高新技术 …See details»
ImmuQuad Biotech - Funding, Financials, Valuation & Investors
ImmuQuad Biotechnologies is a leading national high-tech enterprise in the field of immunogenomics (TCR/BCR) technology. New. Resources. Advanced Search. Start Free …See details»
ImmuQuad Biotech - PitchBook
ImmuQuad Biotech General Information Description. Developer of immune-driven medicine designed to innovate the diagnosis and treatment of disease. The company focuses on …See details»
Hangzhou ImmuQuad Biotechnologies, LLC - synapse.zhihuiya.com
了解Hangzhou ImmuQuad Biotechnologies, LLC (杭州艾沐蒽生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 1篇新闻。See details»
从心出发，向新而行| 艾沐蒽2024年度回顾与展望 - 杭州艾沐蒽生 …
公司地址 浙江省杭州市上城区石桥路196号浙江省农业科创园4楼1层 邮编：310000 联系电话 0571****61561 登录查看商家电话 传真号码 电子邮箱See details»
Genetron licenses Immuquad’s MRD assays in hematologic cancer
Oct 30, 2020 Precision oncology company Genetron Holdings Ltd. has entered an exclusive licensing agreement for Seq-MRD, a diagnostic assay for detecting and monitoring minimal …See details»
Genetron Health Enters Exclusive Global Licensing Agreement
Oct 22, 2020 ImmuQuad is a leading biotechnology company in China focused on developing an immune profiling platform for clinical diagnostics and life sciences research. The Company’s …See details»
你可以什么都不相信，但是一定要相信艾沐蒽的技术！
Jul 2, 2021 导读： 艾沐蒽专注于解码适应性免疫系统来改变疾病的诊断和治疗，致力于推进免疫驱动医学领域的发展。艾沐蒽站在适应性免疫系统研究的最前沿，自主研发的免疫医学平台可 …See details»
ImmuQuad Biotech - Contacts, Employees, Board Members
ImmuQuad Biotechnologies is a leading national high-tech enterprise in the field of immunogenomics (TCR/BCR) technology. New. Resources. Advanced Search. Start Free …See details»
ImmuHub®免疫组测序平台：前沿科技，带您探索免疫奥秘医药新 …
⌈ByDrug医药新闻摘要⌋ 2024-07-12 14:01，艾沐蒽生物科技：艾沐蒽专注于解码适应性免疫系统来改变疾病的诊断和治疗，致力于推进免疫驱动医学领域的发展。 艾沐蒽站在适应性免疫系统 …See details»
ImmuQuad Biotech - Tech Stack, Apps, Patents & Trademarks
ImmuQuad Biotechnologies is a leading national high-tech enterprise in the field of immunogenomics (TCR/BCR) technology. New. Resources. ... Experience the new …See details»
Genetron Health Licenses ImmuQuad Technology for Blood …
Oct 22, 2020 ImmuQuad is eligible to receive high single-digit royalties on product sales for 10 years following commercialization. Genetron has also made a minority equity investment in in …See details»
重要进展！艾沐蒽Seq-MRD®在Nature Communications发表最新 …
⌈ByDrug医药新闻摘要⌋ 2023-11-20 17:13，艾沐蒽生物科技：该研究中所有样本的NGS-MRD检测均采用 艾沐蒽自主开发的Seq-MRD ® 技术 。 这项研究利用二代测序技术（NGS）开展淋巴 …See details»
ImmuHub® | 最全面的免疫组测序建库技术 - immuquad.com
Aug 12, 2022 目前， immuhub ® 免疫组文库构建平台根据样本情况和研究目的主要分为两种技术路线： 1. 多重pcr引物建库：以dna为模板，针对cdr3区设计多对引物，扩增出cdr3区段， …See details»
艾沐蒽生物亮相——2021年第三届全球生物医药前沿技术大会精彩 …
导读： 2021年7月10-12日，「金鸡湖- 2021年第三届全球生物医药前沿技术大会」在苏州国际博览中心顺利召开。 本届大会由同写意新药英才俱乐部策划主办，中国农工民主党中央生物技术 …See details»
Series A - ImmuQuad Biotech - 2020-10-01 - Crunchbase
Series A - ImmuQuad Biotech . Save . Summary. Overview. Edit Overview Section. Organization Name . ImmuQuad Biotech . Announced Date Oct 1, 2020; Funding Type Series A; Funding …See details»
ImmuHub®免疫组测序服务焕新体验｜TCR & BCR七链联检，科研 …
⌈ByDrug医药新闻摘要⌋ 2024-11-14 17:14，艾沐蒽生物科技：ImmuHub ® 5'RACE Ultra 建库技术原理。 ImmuHub ® 5'RACE Ultra建库技术，通过在RNA的5'端加一个我们自主专利技术的接 …See details»
史上最全解析 | BCR测序与应用指导 - immuquad.com
Sep 26, 2024 2、Bruzeau C, Cook-Moreau J, Pinaud E, Le Noir S. Contribution of Immunoglobulin Enhancers to B Cell Nuclear Organization. Front Immunol. 2022 Jun …See details»